TRex Bio, Inc.

US$13.26As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:TRXBHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap US$357.0M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$13
(0.03%)
(90.39%)
Hold 5|2|6|4|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.35
0.39
0.42
0.44
26.29%
31.29%
34.08%
36.20%
Revenue$M
34.46
36.00
35.24
34.25
6.10%
13.67%
13.50%
4.60%
Peers (US$357.0M)
Cap (US$)
PE
356.5M
14.33x
Capital
TTM
5Y
10Y
Leveragex
0.829
0.575
0.463
EBIT/Intx
0.495
0.355
0.439
Own earn%
533.12
(42.19)
(43.41)
Sh yield%
30.62
46.16
47.28
Owners
Insiders/Inst%
2.88
68.77
Short interest%
2.71
SBC / revenue%
1.19
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
9–17
$1 testx
—
Incr. ROIC%
5